SIGNORELLI, Kathy,CZYSTOWSKA, Margareta,EGAN, James,BRANDWEIN, Harvey,WHITESIDE, Theresa,HADDEN, John
申请号：
ES08854580
公开号：
ES2653887T3
申请日:
2008.11.26
申请国别(地区):
ES
年份:
2018
代理人:
摘要：
Use of a natural biological component derived from primary cells comprising interleukin 1β (IL-1β), interleukin 2 (IL-2), interleukin 6 (IL-6), interleukin 8 (IL-8), tumor necrosis factor α ( TNF-α) and interferon γ (IFN-γ), to prolong the life of T cells in vitro.Uso de un componente biológico natural derivado de células primarias que comprende interleucina 1β (IL-1β), interleucina 2 (IL-2), interleucina 6 (IL-6), interleucina 8 (IL-8), factor α de necrosis tumoral (TNF-α) e interferón γ (IFN-γ), para prolongar la vida de las células T in vitro.
